Abstract:
Objective To analyze the blood components of Suanzaoren Decoction after oral administration using UHPLC-Q Exactive Orbitrap-MS technology.
Methods Female Sprague-Dawley (SD) rats were used as experimental subjects, and Suanzaoren Decoction was administered orally. Serum samples were collected, and the aqueous extract of Suanzaoren Decoction and the serum were analyzed using UHPLC-Q Exactive Orbitrap-MS technology to identify the prototype components and metabolites absorbed into the blood by comparing and analyzing with the LuMet-TCM database.
RESULTS It showed that a total of 458 components were identified in the aqueous extract of Suanzaoren Decoction, and 26 chemical components were identified in the blood, including 23 prototype components and 3 metabolites.
CONCLUSION The prototype components absorbed into the blood discovered in this study may be the active ingredients of Suanzaoren Decoction, providing a reference for the research on the pharmacodynamic material basis of Suanzaoren Decoction.